Insulet (PODD) News Today → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free PODD Stock Alerts $187.27 +1.89 (+1.02%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 2:08 PM | investorplace.comFollow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit GainsMay 16 at 1:03 PM | marketbeat.comVanguard Personalized Indexing Management LLC Acquires 6,984 Shares of Insulet Co. (NASDAQ:PODD)Vanguard Personalized Indexing Management LLC boosted its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 168.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 11,118 shares of the medical instruments supplier's stocMay 15, 2024 | marketbeat.comFirst Turn Management LLC Invests $25.03 Million in Insulet Co. (NASDAQ:PODD)First Turn Management LLC bought a new position in shares of Insulet Co. (NASDAQ:PODD - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 115,366 shares of the medical instruments supplier's stock, valuMay 15, 2024 | americanbankingnews.comBarclays Cuts Insulet (NASDAQ:PODD) Price Target to $200.00May 14, 2024 | au.investing.comBlue Orca goes short Insulet on undisclosed preliminary injunction defeatMay 14, 2024 | finance.yahoo.comWall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?May 14, 2024 | finance.yahoo.comWill Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems MarketMay 14, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Insulet (PODD) and Crispr Therapeutics AG (CRSP)May 14, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), Insulet (PODD)May 14, 2024 | americanbankingnews.comRaymond James Lowers Insulet (NASDAQ:PODD) Price Target to $213.00May 14, 2024 | marketbeat.comVictory Capital Management Inc. Cuts Stock Position in Insulet Co. (NASDAQ:PODD)Victory Capital Management Inc. decreased its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 35.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,734 shares of the medical instrMay 14, 2024 | americanbankingnews.comInsulet (NASDAQ:PODD) Price Target Increased to $260.00 by Analysts at Jefferies Financial GroupMay 13, 2024 | benzinga.comWhat the Options Market Tells Us About InsuletMay 13, 2024 | marketbeat.comInsulet (NASDAQ:PODD) PT Lowered to $200.00 at BarclaysBarclays reduced their target price on shares of Insulet from $213.00 to $200.00 and set an "equal weight" rating for the company in a report on Monday.May 13, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 22,247 Shares of Insulet Co. (NASDAQ:PODD)Charles Schwab Investment Management Inc. boosted its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 407,592 shares of the medical iMay 13, 2024 | markets.businessinsider.comInsulet (PODD) Gets a Hold from Stifel NicolausMay 13, 2024 | americanbankingnews.comBrokers Offer Predictions for Insulet Co.'s Q2 2024 Earnings (NASDAQ:PODD)May 13, 2024 | americanbankingnews.comReviewing Insulet (NASDAQ:PODD) & Nemaura Medical (NASDAQ:NMRD)May 13, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Insulet (PODD) and Progyny (PGNY)May 12, 2024 | finance.yahoo.comResults: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New ForecastsMay 12, 2024 | msn.comStreet calls of the week: Micron upgraded, downgrade for ZoomInfoMay 12, 2024 | americanbankingnews.comInsulet (NASDAQ:PODD) PT Raised to $234.00May 11, 2024 | americanbankingnews.comInsulet (NASDAQ:PODD) Sees Unusually-High Trading Volume After Earnings BeatMay 10, 2024 | markets.businessinsider.comInsulet Corporation: Strong Q1 Performance and Positive Growth Outlook Affirm Buy RatingMay 10, 2024 | markets.businessinsider.comBank of America Securities Reaffirms Their Buy Rating on Insulet (PODD)May 10, 2024 | finance.yahoo.comInsulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year GuidanceMay 10, 2024 | finance.yahoo.comInsulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comInsulet (NASDAQ:PODD) Sees Unusually-High Trading Volume on Better-Than-Expected EarningsInsulet (NASDAQ:PODD) Sees Unusually-High Trading Volume on Better-Than-Expected EarningsMay 10, 2024 | marketbeat.comInsulet (NASDAQ:PODD) Price Target Cut to $213.00Raymond James dropped their price objective on Insulet from $218.00 to $213.00 and set an "outperform" rating on the stock in a research note on Friday.May 10, 2024 | marketbeat.comInsulet (NASDAQ:PODD) Releases Quarterly Earnings Results, Beats Estimates By $0.34 EPSInsulet (NASDAQ:PODD - Get Free Report) issued its earnings results on Thursday. The medical instruments supplier reported $0.73 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.34. Insulet had a return on equity of 32.19% and a net margin of 12.16%. The company had revenue of $441.70 million for the quarter, compared to analysts' expectations of $424.05 million. During the same period last year, the business earned $0.23 EPS. Insulet's quarterly revenue was up 23.3% compared to the same quarter last year.May 10, 2024 | marketbeat.comNatixis Advisors L.P. Acquires 19,396 Shares of Insulet Co. (NASDAQ:PODD)Natixis Advisors L.P. boosted its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 185.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,883 shares of the medical instruments supplier's stock after purchasing an addMay 9, 2024 | investorplace.comPODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | marketbeat.comTimesSquare Capital Management LLC Sells 13,200 Shares of Insulet Co. (NASDAQ:PODD)TimesSquare Capital Management LLC cut its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 57.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,800 shares of the medical instrumentsMay 9, 2024 | seekingalpha.comInsulet Corporation 2024 Q1 - Results - Earnings Call PresentationMay 9, 2024 | yahoo.comInsulet misses first-quarter profit estimates as marketing costs weighMay 9, 2024 | msn.comInsulet Non-GAAP EPS of $0.23 misses by $0.16, revenue of $441.7M beats by $18.21MMay 9, 2024 | reuters.comInsulet misses first-quarter profit estimates as marketing costs weighMay 9, 2024 | businesswire.comInsulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-YearMay 9, 2024 | americanbankingnews.comInsulet (NASDAQ:PODD) Stock Rating Upgraded by Wolfe ResearchMay 8, 2024 | marketbeat.comRussell Investments Group Ltd. Sells 7,088 Shares of Insulet Co. (NASDAQ:PODD)Russell Investments Group Ltd. lessened its stake in Insulet Co. (NASDAQ:PODD - Free Report) by 16.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 36,168 shares of the medical instruments supplier's stock after selling 7,May 7, 2024 | msn.comWolfe raises Insulet to outperform, cites increasing market shareMay 7, 2024 | msn.comWolfe Research Upgrades Insulet (PODD)May 7, 2024 | markets.businessinsider.comInsulet’s Market Dominance and Growth Catalysts Prompt ‘Buy’ RatingMay 7, 2024 | finance.yahoo.comInsulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible GrowthMay 7, 2024 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Sold by Swiss National BankSwiss National Bank cut its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 218,300 shares of the medical instrumenMay 7, 2024 | businesswire.comInsulet's 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible GrowthMay 5, 2024 | marketbeat.com53,290 Shares in Insulet Co. (NASDAQ:PODD) Bought by Los Angeles Capital Management LLCLos Angeles Capital Management LLC purchased a new position in Insulet Co. (NASDAQ:PODD - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 53,290 shares of the medical instruments supplier's stock, valuMay 4, 2024 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Sold by Fisher Asset Management LLCFisher Asset Management LLC lowered its position in Insulet Co. (NASDAQ:PODD - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 344,164 shares of the medical instruments supplier's sApril 30, 2024 | marketbeat.comBeck Bode LLC Makes New Investment in Insulet Co. (NASDAQ:PODD)Beck Bode LLC acquired a new position in shares of Insulet Co. (NASDAQ:PODD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 49,388 shares of the medical instruments supplier's stock, valued at approxiApril 29, 2024 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Sold by California Public Employees Retirement SystemCalifornia Public Employees Retirement System cut its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 22.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 99,253 shares of the medical instruments supplier's stock after selling 29,389 shares Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. PODD Media Mentions By Week PODD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PODD News Sentiment▼0.200.42▲Average Medical News Sentiment PODD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PODD Articles This Week▼249▲PODD Articles Average Week Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Teleflex News Baxter International News Globus Medical News NovoCure News ResMed News Shockwave Medical News Solventum News Penumbra News Inspire Medical Systems News Glaukos News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PODD) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford Club41 banks launch ‘crypto dollar’Stansberry ResearchDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insulet Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
